Christina Wolfson, PhD

Primary Axis: 
Health Outcomes
Secondary Axis: 
Neurosciences
Research Focus: 

Research interests are primarily in the epidemiology of degenerative neurological disorders with a primary focus on multiple sclerosis, dementia, and cerebrovascular disease. Recently, studies have also focused on the use of services by seniors and those with neurodegenerative diseases. In addition to substantive research, a program of methodologic research aimed at improving design, measurement and statistical analyses of epidemiologic studies has been maintained.Neurepidemiology, Multiple sclerosis, Alzheimer’s disease, biostatistics, health services, dementia, geriatrics, population research, neurology, neurodegenerative diseases

Keywords: 
Neurepidemiology, Multiple sclerosis, Alzheimer’s disease, biostatistics, health services, dementia, geriatrics, population research, neurology, neurodegenerative diseases
Location: 
Royal Victoria Hospital
Publications:
Wolfson C, Wolfson DB, Asgharian M, M’Lan C for the Clinical Progression of Dementia Working Group. A re-evaluation of the duration of survival from the onset of dementia. New England Journal of Medicine 2001; 344: 1111-1116.
Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y. Donepezil and Rivastigmine in the Treatment of Alzheimer’s Disease: A Best Evidence Synthesis of the Evidence for Efficacy and Cost-Effectiveness. Clinical Therapeutics 2002; 24: 862-866.
Wolfson C. [Editorial] Multiple Sclerosis and antecedent infections. Epidemiology 2001; 12: 298-299.